CME Pre-Test

Your Name:
Email Or Phone Number:
AAFP Member Number (if applicable):

AAFP: This activity has been reviewed and is acceptable for up to 2.0 Prescribed credit(s) by the American Academy of Family Physicians. Of these credits, .75 conforms to the AAFP criteria for evidence-based CME clinical content. CME credit has been increased to reflect 2 for 1 credit for only the EB CME portion. AAFP accreditation begins 4/30/2009. The term of approval is for two year(s) from this date, with option for yearly renewal. When reporting AAFP credit, report total Prescribed and Elective credit for this activity. It is not necessary to label credit as evidence-based CME for reporting purposes.

The EB CME credit awarded for this activity was based on practice recommendations that were the most current with the strongest level of evidence available at the time this activity was approved. Since clinical research is ongoing, AAFP recommends that learners verify sources and review these and other recommendations prior to implementation into practice.

AMA: The Georgia Academy of Family Physicians is accredited by the Medical Association of Georgia to offer continuing medical education to physicians. The GAFP designates this educational activity for a maximum of 1.5 AMA PRA Category 1 creditsTM toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AANP: This program is approved for 1.3 contact hour(s) of continuing education (which includes 1.3 hour(s) pharmacology). This program was planned in accordance with American Academy of Nurse Practitioners (AANP) CE Standards and Policies and AANP Commercial Support Standards. Program ID #0901029.

Please choose the best answer for the following questions.

1. Increasing the proportion of women of reproductive age who receive evidence-based preconception care is a national goal because of the potential to contribute to which of the following?
A reduction in infant mortality
A reduction in maternal mortality and maternal complications of pregnancy
A reduction in the number of infants born with congenital anomalies
A reduction in the number of unintended pregnancies
All of the above
 
2. The leading cause of infant mortality in the United States is which of the following?
Congenital anomalies
Respiratory infections
Sudden infant death syndrome
Injuries and accidents
 
3. At the mean entry point into prenatal care (11-12 weeks' since the last menstrual period), the process of organogenesis for most organ systems is in the early phase.
True
False
 
4. Which of the following are modifiable risks that increase a woman's chance of having an infant with a congenital anomaly?
Exposure to teratogenic medications during the first trimester of pregnancy
Poorly-controlled chronic conditions (e.g., seizures, diabetes) during a pregnancy
Contracting rubella during the first trimester of pregnancy
Lack of appropriate folic acid supplementation during the first trimester of pregnancy
All of the above
 
5. The appropriate dosage and timing of initiation of folic acid supplementation is as follows:
A. For women at average risk who are planning a pregnancy, 400 micrograms daily initiated three months prior to conception
B. For all women of reproductive age, 400 micrograms daily regardless of pregnancy plans
C. For women with seizure disorders, 4 mg daily initiated at least one month prior to conception until the end of the first trimester
A and C
B and C
 
6. A woman at average risk for having an infant with a neural tube defect is typically able to consume sufficient folate to prevent neural tube defects through a diet rich in leafy green vegetables.
True
False
 
7. For women with hypothyroidism, their thyroid replacement requirements typically decrease early in pregnancy
True
False
 
8. Women with conditions requiring anticoagulant therapy who are planning a pregnancy or who might become pregnant should avoid which anticoagulants:
Warfarin
Heparin
Low-molecular-weight heparin
All of the above
 
9. Women with seizure disorders are at increased risk of having an infant with a congenital anomaly due to which of the following:
Uncontrolled maternal seizures
Exposure to anticonvulsant medications
Both of the above
Neither of the above
 
10. The leading preventable cause of mental retardation in the United States is which of the following:
Chromosomal anomalies
Neonatal anoxia (birth asphyxia)
Maternal alcohol use
Maternal iodine deficiency
 
11. The leading preventable cause of low birth weight delivery is the following:
Chromosomal anomalies
Maternal tobacco use
Maternal nutritional deficiencies
Maternal underweight
 
12. For woman with Type II diabetes who are planning a pregnancy or who might become pregnant, evidence supports that the HgA1c should be maintained within the following range during organogenesis to decrease the risk of congenital malformations:
< 1% above normal range
1-2% above normal range
2-3% above normal range
None of the above